mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.4 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |